Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Non Operating Income: 2010-2025

Historic Non Operating Income for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Sep 2025 value amounting to -$46.8 million.

  • Arrowhead Pharmaceuticals' Non Operating Income rose 37.37% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.8 million, marking a year-over-year decrease of 245.87%. This contributed to the annual value of -$46.8 million for FY2025, which is 311.36% down from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Non Operating Income of -$46.8 million as of FY2025, which was down 311.36% from -$11.4 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Non Operating Income registered a high of $8.2 million during FY2021, and its lowest value of -$46.8 million during FY2025.
  • Its 3-year average for Non Operating Income is -$18.9 million, with a median of -$11.4 million in 2024.
  • Data for Arrowhead Pharmaceuticals' Non Operating Income shows a maximum YoY slumped of 839.92% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Arrowhead Pharmaceuticals' Non Operating Income stood at $8.2 million in 2021, then fell by 29.21% to $5.8 million in 2022, then crashed by 73.47% to $1.5 million in 2023, then tumbled by 839.92% to -$11.4 million in 2024, then crashed by 311.36% to -$46.8 million in 2025.